Eos BioInnovation is a Cambridge-based venture capital firm that incubates, launches, and invests in early-stage regenerative medicine companies in the United States. It focuses on curative therapies and enabling technologies across biotechnology, life sciences, pharmaceuticals, cell and gene therapies, and engineered biomaterials, with emphasis on academic-lab spinouts and strategic company building. The firm has acted as a lead investor in seed financing, making it relevant for founders developing early-stage therapeutic or regenerative medicine platforms.